Scleroderma drug trial shows up to 60% improvement
Drug Discovery World
NOVEMBER 30, 2023
Transcriptomic analysis indicated that the systemic fibrotic disease gene signature is modulated after 12 weeks, with an increased fibrosis signature score in the placebo group but significantly, a decrease in the same fibrosis signature score following FT011 400mg treatment.
59 
Let's personalize your content